Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Cervical Cancer, January 2021

Free Subscription


Abstracts

Retrieve all available abstracts of the following 278 articles:
HTML format


 

Single Articles

  1. KLYUCHKO KO, Gargin VV
    Influence of neoadjuvant chemoradiotherapy for locally advanced cervical cancer.
    Pol Merkur Lekarski. 2020;48:406-409.
    PubMed    
    Abstract available

  2. WANG W, Xu A, Zhao M, Sun J, et al
    Circ_0001247 functions as a miR-1270 sponge to accelerate cervical cancer progression by up-regulating ZEB2 expression level.
    Biotechnol Lett. 2021 Jan 1. pii: 10.1007/s10529-020-03059.
    PubMed    
    Abstract available

  3. MENDIA A, Shah CP, Grajo JR, Yachnis A, et al
    Orbital metastasis of squamous cell cervical cancer: A case report and review of literature.
    Gynecol Oncol Rep. 2020;35:100689.
    PubMed    
    Abstract available

  4. BHOCHHIBHOYA S, Dobbs PD, Maness SB
    Interventions using mHealth strategies to improve screening rates of cervical cancer: A scoping review.
    Prev Med. 2020;143:106387.
    PubMed    
    Abstract available

  5. CHEN W, Shen X, Ma L, Chen R, et al
    Phenolic Compounds from Polygonum chinense Induce Growth Inhibition and Apoptosis of Cervical Cancer SiHa Cells.
    Biomed Res Int. 2020;2020:8868508.
    PubMed    
    Abstract available

  6. WANG J, Zheng H, Han Y, Wang G, et al
    A Novel Four-Gene Prognostic Signature as a Risk Biomarker in Cervical Cancer.
    Int J Genomics. 2020;2020:4535820.
    PubMed    
    Abstract available

  7. CHUANG PC, Lu CW, Tsai CC, Tseng SH, et al
    MicroRNA-128 Confers Anti-Endothelial Adhesion and Anti-Migration Properties to Counteract Highly Metastatic Cervical Cancer Cells' Migration in a Parallel-Plate Flow Chamber.
    Int J Mol Sci. 2020;22.
    PubMed    
    Abstract available

  8. YANG CM, Sung FC, Hsue CS, Muo CH, et al
    Comparisons of Papanicolaou Utilization and Cervical Cancer Detection between Rural and Urban Women in Taiwan.
    Int J Environ Res Public Health. 2020;18.
    PubMed    
    Abstract available

  9. ZHANG J, Zhao Y, Dai Y, Dang L, et al
    Effectiveness of High-risk Human Papillomavirus Testing for Cervical Cancer Screening in China: A Multicenter, Open-Label, Randomized Clinical Trial.
    JAMA Oncol. 2020 Dec 30. pii: 2774442. doi: 10.1001/jamaoncol.2020.6575.
    PubMed    
    Abstract available

  10. KRISHNAMURTHY S, Yoda H, Hiraoka K, Inoue T, et al
    Targeting the mutant PIK3CA gene by DNA-alkylating pyrrole imidazole polyamide in cervical cancer.
    Cancer Sci. 2020 Dec 29. doi: 10.1111/cas.14785.
    PubMed    
    Abstract available

  11. HENKE A, Kluge U, Borde T, Mchome B, et al
    Tanzanian women s knowledge about Cervical Cancer and HPV and their prevalence of positive VIA cervical screening results. Data from a Prevention and Awareness Campaign in Northern Tanzania, 2017 - 2019.
    Glob Health Action. 2021;14:1852780.
    PubMed    
    Abstract available

  12. HSIEH YS, Chu SC, Huang SC, Kao SH, et al
    Gossypol Reduces Metastasis and Epithelial-Mesenchymal Transition by Targeting Protease in Human Cervical Cancer.
    Am J Chin Med. 2020 Dec 26:1-18. doi: 10.1142/S0192415X21500105.
    PubMed    
    Abstract available

  13. CACERES-DURAN MA, Ribeiro-Dos-Santos A, Vidal AF
    Roles and Mechanisms of the Long Noncoding RNAs in Cervical Cancer.
    Int J Mol Sci. 2020;21.
    PubMed    
    Abstract available

  14. NAKAO Y, Sasaki AI, Obara T, Abe S, et al
    Knowledge of Cervical Cancer and Human Papillomavirus among Japanese Women.
    Asian Pac J Cancer Prev. 2020;21:3527-3532.
    PubMed    
    Abstract available

  15. HE S, Xu M, Xiong Z, Hu Y, et al
    Predictive value of protease-activated receptor-2 (PAR2 ) in cervical cancer metastasis.
    J Cell Mol Med. 2020 Dec 23. doi: 10.1111/jcmm.16227.
    PubMed    
    Abstract available

  16. LI M, Zhao Y, Qie M, Zhang Y, et al
    Management of Cervical Cancer in Pregnant Women: A Multi-Center Retrospective Study in China.
    Front Med (Lausanne). 2020;7:538815.
    PubMed    
    Abstract available

  17. XIE Y, Feng Y, Li W, Zhan F, et al
    Revealing the Disturbed Vaginal Micobiota Caused by Cervical Cancer Using High-Throughput Sequencing Technology.
    Front Cell Infect Microbiol. 2020;10:538336.
    PubMed    
    Abstract available

  18. FENG X, Chen H, Li L, Gao L, et al
    Postoperative Adjuvant Chemotherapy Improved the Prognosis in Locally Advanced Cervical Cancer Patients With Optimal Response to Neoadjuvant Chemotherapy.
    Front Oncol. 2020;10:608333.
    PubMed    
    Abstract available

  19. ZHANG Y, Li B, Wang Y, Liu S, et al
    Paclitaxel Plus Platinum Neoadjuvant Chemotherapy Followed by Surgery Versus Primary Surgery in Locally Advanced Cervical Cancer-A Propensity Score Matching Analysis.
    Front Oncol. 2020;10:604308.
    PubMed    
    Abstract available

  20. CHAO X, Fan J, Song X, You Y, et al
    Diagnostic Strategies for Recurrent Cervical Cancer: A Cohort Study.
    Front Oncol. 2020;10:591253.
    PubMed    
    Abstract available

  21. MA T, Guo R, Wang X, Shen WT, et al
    Lentiviral vector with a radiation-inducible promoter, carrying the ING4 gene, mediates radiosensitization controlled by radiotherapy in cervical cancer cells.
    Oncol Lett. 2021;21:67.
    PubMed    
    Abstract available

  22. TORRADO-GARCIA LM, Martinez-Vega RA, Rincon-Orozco B
    A Novel Strategy for Cervical Cancer Prevention Using Cervical-Vaginal Self-Collected Samples Shows High Acceptability in Women Living in Low-Income Conditions from Bucaramanga, Colombia.
    Int J Womens Health. 2020;12:1197-1204.
    PubMed    
    Abstract available

  23. SHI X, Wang J, Dai S, Qin L, et al
    Apolipoprotein C1 (APOC1): A Novel Diagnostic and Prognostic Biomarker for Cervical Cancer.
    Onco Targets Ther. 2020;13:12881-12891.
    PubMed    
    Abstract available

  24. MEDINA-JIMENEZ AK, Monroy-Torres R
    Repurposing Individualized Nutritional Intervention as a Therapeutic Component to Prevent the Adverse Effects of Radiotherapy in Patients With Cervical Cancer.
    Front Oncol. 2020;10:595351.
    PubMed    
    Abstract available

  25. ZHONG G, Fang X, Xie Q, Wang Y, et al
    Long non-coding RNA AK001903 regulates tumor progression in cervical cancer.
    Oncol Lett. 2021;21:77.
    PubMed    
    Abstract available

  26. VOINEA S, Herghelegiu CG, Sandru A, Ioan RG, et al
    Impact of histological subtype on the response to chemoradiation in locally advanced cervical cancer and the possible role of surgery.
    Exp Ther Med. 2021;21:93.
    PubMed    
    Abstract available

  27. ALEMNEW W, Debalkie G, Azale T
    Intention to Screen for Cervical Cancer Among Child Bearing Age Women in Bahir Dar City, North-West Ethiopia: Using Theory of Planned Behavior.
    Int J Womens Health. 2020;12:1215-1222.
    PubMed    
    Abstract available

  28. GUAN L
    Endostar Rebuilding Vascular Homeostasis and Enhancing Chemotherapy Efficacy in Cervical Cancer Treatment.
    Onco Targets Ther. 2020;13:12811-12827.
    PubMed    
    Abstract available

  29. GUZIN K, Kinter AK, Bozdag H, Kir G, et al
    Vaginal epithelioid malignant peripheral nerve sheath tumor nearly misdiagnosed as advanced cervical cancer: A case report.
    Int J Surg Case Rep. 2020;78:241-246.
    PubMed    
    Abstract available

  30. WANG C, Kuang L, Han L
    MiR-374b increases the CIK expression and mediates biological function changes in cervical cancer cells by targeting the PD-1/PD-L1 signaling pathway.
    J Reprod Immunol. 2020;143:103265.
    PubMed    
    Abstract available

  31. YU Y, Ma J, Zhao W, Li Z, et al
    MSCI: A multistate dataset for colposcopy image classification of cervical cancer screening.
    Int J Med Inform. 2020;146:104352.
    PubMed    
    Abstract available

  32. SMITH AJB, Jones TN, Miao D, Fader AN, et al
    Minimally Invasive Radical Hysterectomy for Cervical Cancer: A Systematic Review and Meta-analysis.
    J Minim Invasive Gynecol. 2020 Dec 23. pii: S1553-4650(20)31197.
    PubMed    
    Abstract available

  33. ROBLES C, Bruni L, Acera A, Riera JC, et al
    Determinants of Human Papillomavirus Vaccine Uptake by Adult Women Attending Cervical Cancer Screening in 9 European Countries.
    Am J Prev Med. 2020 Dec 24. pii: S0749-3797(20)30434.
    PubMed    
    Abstract available

  34. ABDOLALIPOUR E, Mahooti M, Gorji A, Ghaemi A, et al
    Synergistic Therapeutic Effects of Probiotic Lactobacillus casei TD-2 Consumption on GM-CSF-Induced Immune Responses in a Murine Model of Cervical Cancer.
    Nutr Cancer. 2020 Dec 26:1-11. doi: 10.1080/01635581.2020.1865419.
    PubMed    
    Abstract available

  35. GHALAVANDI S, Heidarnia A, Zarei F, Beiranvand R, et al
    Knowledge, attitude, practice, and self-efficacy of women regarding cervical cancer screening.
    Obstet Gynecol Sci. 2020 Dec 28. pii: ogs.20236. doi: 10.5468/ogs.20236.
    PubMed    
    Abstract available

  36. YAMADA Y, Tomita N, Kitagawa Y, Imai M, et al
    Vaginal Fistulas of the Bladder and Small Bowel After Two-Dimensional Intracavitary Brachytherapy in a Patient With Cervical Cancer.
    Cureus. 2020;12:e11537.
    PubMed    
    Abstract available

  37. GAO L, Pang YY, Guo XY, Zeng JJ, et al
    Polo like kinase 1 expression in cervical cancer tissues generated from multiple detection methods.
    PeerJ. 2020;8:e10458.
    PubMed    
    Abstract available

  38. REYNEKE F, Snyman LC, Lawal I, Lengana T, et al
    Diagnostic value of sentinel lymph node scintigraphy and 2-[(18)F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the detection of metastatic lymph nodes in patients with early-stage cervical cancer.
    World J Nucl Med. 2020;19:240-245.
    PubMed    
    Abstract available

  39. NIGUSSIE T, Asefa A, Nigusse A, Admassu B, et al
    Knowledge Toward Cervical Cancer and Its Determinants Among Women Aged 30-49 in Jimma Town, Southwest Ethiopia.
    Cancer Control. 2020;27:1073274820983027.
    PubMed    
    Abstract available

  40. LI D, Hu C, Yang J, Liao Y, et al
    Enhanced Anti-Cancer Effect of Folate-Conjugated Olaparib Nanoparticles Combined with Radiotherapy in Cervical Carcinoma.
    Int J Nanomedicine. 2020;15:10045-10058.
    PubMed    
    Abstract available

  41. MASUDA T, Ogawa K, Kamatani Y, Murakami Y, et al
    A Mendelian randomization study identified obesity as a causal risk factor of uterine endometrial cancer in Japanese.
    Cancer Sci. 2020;111:4646-4651.
    PubMed    
    Abstract available

  42. ZHANG B, Yue ZY, Yang ZM, Nan P, et al
    [The screening value of the numerical control standardized cell block preparation technique in high-grade squamous epithelial lesions of the cervix].
    Zhonghua Bing Li Xue Za Zhi. 2020;49:842-844.
    PubMed    


  43. DA SILVA RL, da Silva Batista Z, Bastos GR, Cunha APA, et al
    Role of HPV 16 variants among cervical carcinoma samples from Northeastern Brazil.
    BMC Womens Health. 2020;20:162.
    PubMed    
    Abstract available

  44. DU X, Li M, Zhou Y, Yang H, et al
    Evidence of Passive Smoking as a Risk Factor of High-Grade Squamous Intraepithelial Lesion: A Case-Control Study.
    Biol Pharm Bull. 2020;43:1061-1066.
    PubMed    
    Abstract available

  45. GOYAL A, Patel AP, Dilcher TL, Alperstein SA, et al
    Effects of Implementing the Dual Papanicolaou Test Interpretation of ASC-H and LSIL Following Bethesda 2014.
    Am J Clin Pathol. 2020;154:553-558.
    PubMed    
    Abstract available

  46. KARANI LW, Musyoki S, Orina R, Nyamache AK, et al
    Human papillomavirus genotype profiles and cytological grades interlinkages in coinfection with HIV.
    Pan Afr Med J. 2020;35:67.
    PubMed    
    Abstract available

  47. ARMBRUSTER SD, Fellman BM, Jhingran A, Eifel PJ, et al
    A phase III study of transdermal granisetron versus oral ondansetron for women with gynecologic cancers receiving pelvic chemoradiation.
    Support Care Cancer. 2021;29:213-222.
    PubMed    
    Abstract available

  48. LI B, Guo X, Li N, Chen Q, et al
    WNT1, a target of miR-34a, promotes cervical squamous cell carcinoma proliferation and invasion by induction of an E-P cadherin switch via the WNT/beta-catenin pathway.
    Cell Oncol (Dordr). 2020;43:489-503.
    PubMed    
    Abstract available

  49. YOSHIHARA M, Shimono R, Tsuru S, Kitamura K, et al
    Risk factors for late-onset lower limb lymphedema after gynecological cancer treatment: A multi-institutional retrospective study.
    Eur J Surg Oncol. 2020;46:1334-1338.
    PubMed    
    Abstract available

  50. MUELLER JJ, Dauer LT, Murali R, Iasonos A, et al
    Positron Lymphography via Intracervical (18)F-FDG Injection for Presurgical Lymphatic Mapping in Cervical and Endometrial Malignancies.
    J Nucl Med. 2020;61:1123-1130.
    PubMed    
    Abstract available

  51. ROHNER E, Rahangdale L, Sanusi B, Knittel AK, et al
    Test Accuracy of Human Papillomavirus in Urine for Detection of Cervical Intraepithelial Neoplasia.
    J Clin Microbiol. 2020;58.
    PubMed    
    Abstract available

  52. MURAKAMI N, Nakamura S, Kashihara T, Kato T, et al
    Hyaluronic acid gel injection in rectovaginal septum reduced incidence of rectal bleeding in brachytherapy for gynecological malignancies.
    Brachytherapy. 2020;19:154-161.
    PubMed    
    Abstract available

  53. D'CUNHA P, Pinho DF, Nwachukwu C, Xi Y, et al
    Updating and optimizing anatomical atlases for elective radiation of para-aortic lymph nodes in cervical cancer.
    Pract Radiat Oncol. 2021 Jan 6. pii: S1879-8500(20)30306.
    PubMed    
    Abstract available

  54. XU J, Tan ZC, Shen ZY, Shen XJ, et al
    Cordyceps cicadae polysaccharides inhibit Human cervical cancer Hela cells proliferation via Apoptosis and Cell Cycle Arrest.
    Food Chem Toxicol. 2021 Jan 6:111971. doi: 10.1016/j.fct.2021.111971.
    PubMed    
    Abstract available

  55. DI MARTINO G, Lissoni AA, Ferrari D, DI Meo ML, et al
    Dose-dense Neoadjuvant Chemotherapy With Paclitaxel and Carboplatin in Cervical Cancer: Efficacy on Pathological Response.
    Anticancer Res. 2021;41:497-502.
    PubMed    
    Abstract available

  56. MUNOZ-ZULUAGA CA, Gallo-Perez JD, Perez-Bustos A, Orozco-Urdaneta M, et al
    Mobile Applications: Breaking Barriers to Early Breast and Cervical Cancer Detection in Underserved Communities.
    JCO Oncol Pract. 2021 Jan 8:OP2000665. doi: 10.1200/OP.20.00665.
    PubMed    
    Abstract available

  57. ZHAO Y, Liang X, Wei L, Liu Y, et al
    RNF114 suppresses metastasis through regulation of PARP10 in cervical cancer cells.
    Cancer Commun (Lond). 2021 Jan 8. doi: 10.1002/cac2.12132.
    PubMed    


  58. MENG Q, Zhang B, Zhang Y, Wang S, et al
    Human bone marrow mesenchymal stem cell-derived extracellular vesicles impede the progression of cervical cancer via the miR-144-3p/CEP55 pathway.
    J Cell Mol Med. 2021 Jan 8. doi: 10.1111/jcmm.15573.
    PubMed    
    Abstract available

  59. TRYBUS W, Krol T, Trybus E, Stachurska A, et al
    The potential antitumor effect of chrysophanol in relation to cervical cancer cells.
    J Cell Biochem. 2021 Jan 8. doi: 10.1002/jcb.29891.
    PubMed    
    Abstract available

  60. FERRANTE G, Castagno R, Rizzolo R, Armaroli P, et al
    A comparison of diagnostic indicators of cervical cancer screening among women accessing through volunteer organisations and those via the organised programme in Turin (Piedmont Region, Northern Italy).
    Epidemiol Prev. 2020;44.
    PubMed    
    Abstract available

  61. KANEYASU Y, Fujiwara H, Nishimura T, Sakurai H, et al
    A multi-institutional survey of the quality of life after treatment for uterine cervical cancer: a comparison between radical radiotherapy and surgery in Japan.
    J Radiat Res. 2021 Jan 7. pii: 6067544. doi: 10.1093.
    PubMed    
    Abstract available

  62. LIU Z, Zhao Y, Li Y, Sun J, et al
    Imaging-guided brachytherapy for locally advanced cervical cancer: the main process and common techniques.
    Am J Cancer Res. 2020;10:4165-4177.
    PubMed    
    Abstract available

  63. HAN X, Yang Q, Zhang J, Cao J, et al
    Correlation between changes in the number of peripheral blood lymphocytes and survival rate in patients with cervical cancer after radio-chemotherapy.
    Cancer Radiother. 2021 Jan 4. pii: S1278-3218(20)30344.
    PubMed    
    Abstract available

  64. CHIBONDA S, Ndlovu N, Tsikai N, Munangaidzwa L, et al
    Working title: high dose rate intra-cavitary brachytherapy with cobalt 60 source for locally advanced cervical cancer: the Zimbabwean experience.
    Infect Agent Cancer. 2021;16:1.
    PubMed    
    Abstract available

  65. TAN X, Li K, Zhang J, Wang W, et al
    Automatic model for cervical cancer screening based on convolutional neural network: a retrospective, multicohort, multicenter study.
    Cancer Cell Int. 2021;21:35.
    PubMed    
    Abstract available

  66. CHEN Y, Geng Y, Huang J, Xi D, et al
    CircNEIL3 promotes cervical cancer cell proliferation by adsorbing miR-137 and upregulating KLF12.
    Cancer Cell Int. 2021;21:34.
    PubMed    
    Abstract available

  67. LI P, Wang J, Zhi L, Cai F, et al
    Linc00887 suppresses tumorigenesis of cervical cancer through regulating the miR-454-3p/FRMD6-Hippo axis.
    Cancer Cell Int. 2021;21:33.
    PubMed    
    Abstract available

  68. HAMDIUI N, Marchena E, Stein ML, van Steenbergen JE, et al
    Decision-making, barriers, and facilitators regarding cervical cancer screening participation among Turkish and Moroccan women in the Netherlands: a focus group study.
    Ethn Health. 2021 Jan 7:1-19. doi: 10.1080/13557858.2020.1863921.
    PubMed    
    Abstract available

  69. SARASWATI W, Wardani R, Suhatno, Hartono P, et al
    The Effect of Electroacupuncture Therapy on Pain, Plasma beta-Endorphin, and Quality of Life of Stage III Cervical Cancer Patients: A Randomized Control Trial.
    J Acupunct Meridian Stud. 2021 Jan 4. pii: S2005-2901(20)30179.
    PubMed    
    Abstract available

  70. ADEWUMI K, Nishimura H, Oketch SY, Adsul P, et al
    Barriers and Facilitators to Cervical Cancer Screening in Western Kenya: a Qualitative Study.
    J Cancer Educ. 2021 Jan 7. pii: 10.1007/s13187-020-01928.
    PubMed    
    Abstract available

  71. KUE J, Szalacha LA, Happ MB, Menon U, et al
    Perceptions of Cervical Cancer and Screening Behavior among Cambodian and Lao Women in the United States: An Exploratory, Mixed-Methods Study.
    J Health Care Poor Underserved. 2020;31:889-908.
    PubMed    
    Abstract available

  72. CAO MM, Liu QX, Zou X, Fan XC, et al
    Identification of a serum three-microRNA signature for cervical cancer diagnosis.
    Chin Med J (Engl). 2021;Publish Ahead of Print.
    PubMed    


  73. FAN S, Zhao S, Gao X, Qin Q, et al
    Circular RNA circGSE1 Promotes Cervical Cancer Progression Through miR-138-5p/Vimentin.
    Onco Targets Ther. 2020;13:13371-13386.
    PubMed    
    Abstract available

  74. ZHANG Y, Li X, Zhang J, Mao L, et al
    Circ-CCDC66 upregulates REXO1 expression to aggravate cervical cancer progression via restraining miR-452-5p.
    Cancer Cell Int. 2021;21:20.
    PubMed    
    Abstract available

  75. HAN X, Zhong S, Zhang P, Liu Y, et al
    Identification of differentially expressed proteins and clinicopathological significance of HMGB2 in cervical cancer.
    Clin Proteomics. 2021;18:2.
    PubMed    
    Abstract available

  76. ARAKAWA A, Ichikawa H, Kubo T, Motoi N, et al
    Vaginal Transmission of Cancer from Mothers with Cervical Cancer to Infants.
    N Engl J Med. 2021;384:42-50.
    PubMed    
    Abstract available

  77. WANG J, Zheng CX, Ma CL, Zheng XX, et al
    Raman spectroscopic study of cervical precancerous lesions and cervical cancer.
    Lasers Med Sci. 2021 Jan 6. pii: 10.1007/s10103-020-03218.
    PubMed    
    Abstract available

  78. STEFANOWICZ-HAJDUK J, Gucwa M, Moniuszko-Szajwaj B, Stochmal A, et al
    Bersaldegenin-1,3,5-orthoacetate induces caspase-independent cell death, DNA damage and cell cycle arrest in human cervical cancer HeLa cells.
    Pharm Biol. 2021;59:54-65.
    PubMed    
    Abstract available

  79. CHEN H, Wang T, Huang S, Zeng P, et al
    New novel non-MHC genes were identified for cervical cancer with an integrative analysis approach of transcriptome-wide association study.
    J Cancer. 2021;12:840-848.
    PubMed    
    Abstract available

  80. CHEN H, Wang X, Jia H, Tao Y, et al
    Bioinformatics Analysis of Key Genes and Pathways of Cervical Cancer.
    Onco Targets Ther. 2020;13:13275-13283.
    PubMed    
    Abstract available

  81. SRINIVAS V, Nishimura HM, Jayakrishna P, Krupp K, et al
    Evaluating the feasibility of utilizing Gynocular-triage-to-diagnose application with VIA (Visual inspection with Acetic acid) in community cervical cancer screening programs in rural Mysore, India.
    Indian J Cancer. 2021 Jan 6. pii: 297014. doi: 10.4103.
    PubMed    
    Abstract available

  82. GUO Y, Feng Y, Fan P, Yao X, et al
    Expression and Clinical Significance of KLRG1 and 2B4 on T Cells in the Peripheral Blood and Tumour of Patients with Cervical Cancer.
    Immunol Invest. 2021 Jan 6:1-18. doi: 10.1080/08820139.2020.1867567.
    PubMed    
    Abstract available

  83. DING Y, Yuan X, Gu W
    Circular RNA RBM33 contributes to cervical cancer progression via modulation of the miR-758-3p/PUM2 axis.
    J Mol Histol. 2021 Jan 5. pii: 10.1007/s10735-020-09933.
    PubMed    
    Abstract available

  84. SUN PL, Liu AJ, Gao HW
    [Pathological diagnosis and recent advances of gastric-type uterine cervical lesions].
    Zhonghua Bing Li Xue Za Zhi. 2021;50:69-73.
    PubMed    


  85. XU H, Zhang J
    [Interpretation of updated pathological contents for cervical cancer in NCCN clinical practice guidelines, version 1, 2020].
    Zhonghua Bing Li Xue Za Zhi. 2021;50:9-13.
    PubMed    


  86. CHIANG AJ, Li CJ, Tsui KH, Chang C, et al
    UBE2C Drives Human Cervical Cancer Progression and Is Positively Modulated by mTOR.
    Biomolecules. 2020;11.
    PubMed    
    Abstract available

  87. AIGNER KR, Lavinski Y, Gailhofer S
    Tumor response and the quality of life after isolated hypoxic pelvic perfusion for advanced G3 cervical cancer: A case series.
    Int J Surg Case Rep. 2020;77:816-821.
    PubMed    
    Abstract available


  88. Retraction of: microRNA-34a-Upregulated Retinoic Acid-Inducible Gene-I Promotes Apoptosis and Delays Cell Cycle Transition in Cervical Cancer Cells by Wang J-H, et al. DNA Cell Biol 2016;35(6):267-279; DOI: 10.1089/dna.2015.3130.
    DNA Cell Biol. 2021 Jan 4. doi: 10.1089/dna.2015.3130.
    PubMed    


  89. WANG Y, Ouyang Y, Su J, Xiao L, et al
    Is salvage radiotherapy optimal to patients with occult cervical cancer undergoing inadvertent simple hysterectomy? A propensity score-matched analysis of a nationwide clinical oncology database.
    Jpn J Clin Oncol. 2021 Jan 5. pii: 6055949. doi: 10.1093.
    PubMed    
    Abstract available

  90. MEHTA N, Raker C, Robison K
    Cervical Cancer Prevention: Screening Among Undocumented Hispanic Women Compared With Documented Hispanic Women.
    J Low Genit Tract Dis. 2020;Publish Ahead of Print.
    PubMed    
    Abstract available

  91. LI X, Zhang C, Tian Y
    Long non-coding RNA TDRG1 promotes hypoxia-induced glycolysis by targeting the miR-214-5p/SEMA4C axis in cervical cancer cells.
    J Mol Histol. 2021 Jan 4. pii: 10.1007/s10735-020-09944.
    PubMed    
    Abstract available

  92. ZHANG L, Guo C, Ji T, Chen X, et al
    SOX2 Regulates lncRNA CCAT1/MicroRNA-185-3p/FOXP3 Axis to Affect the Proliferation and Self-Renewal of Cervical Cancer Stem Cells.
    Nanoscale Res Lett. 2021;16:2.
    PubMed    
    Abstract available

  93. LIU D, Zhang X, Zheng T, Shi Q, et al
    Optimisation and evaluation of the random forest model in the efficacy prediction of chemoradiotherapy for advanced cervical cancer based on radiomics signature from high-resolution T2 weighted images.
    Arch Gynecol Obstet. 2021 Jan 4. pii: 10.1007/s00404-020-05908.
    PubMed    
    Abstract available

  94. DEURA I, Kanamori R, Nagasawa Y, Kuji S, et al
    A simple technique of vaginal cuff closure to prevent tumor cell spillage in laparoscopic radical hysterectomy for uterine cervical cancer.
    Asian J Endosc Surg. 2021 Jan 3. doi: 10.1111/ases.12915.
    PubMed    
    Abstract available

  95. LIN Y, Li Z, Liu M, Ye H, et al
    CD34 and Bcl-2 as predictors for the efficacy of neoadjuvant chemotherapy in cervical cancer.
    Arch Gynecol Obstet. 2021 Jan 3. pii: 10.1007/s00404-020-05921.
    PubMed    
    Abstract available

  96. CHO WK, Kim H, Park W, Kim SW, et al
    A dummy-run evaluation of postoperative hypofractionated intensity-modulated radiation therapy (POHIM-RT) trials for cervical cancer.
    J Radiat Res. 2021;62:149-154.
    PubMed    
    Abstract available

  97. SOUZA JL, Martins-Cardoso K, Guimaraes IS, de Melo AC, et al
    Interplay Between EGFR and the Platelet-Activating Factor/PAF Receptor Signaling Axis Mediates Aggressive Behavior of Cervical Cancer.
    Front Oncol. 2020;10:557280.
    PubMed    
    Abstract available

  98. YU DY, Bai YL, Feng Y, Wang L, et al
    Which Bone Marrow Sparing Strategy and Radiotherapy Technology Is Most Beneficial in Bone Marrow-Sparing Intensity Modulated Radiation Therapy for Patients With Cervical Cancer?
    Front Oncol. 2020;10:554241.
    PubMed    
    Abstract available

  99. MALIKOVA H, Burghardtova M, Fejfarova K, Nadova K, et al
    Advanced cervical cancer in young women: imaging study of late and very late radiation-related side effects after successful treatment by combined radiotherapy.
    Quant Imaging Med Surg. 2021;11:21-31.
    PubMed    
    Abstract available

  100. WANG Z, Wang W, Yang A, Zhao W, et al
    Lower dietary mineral intake is significantly associated with cervical cancer risk in a population-based cross-sectional study.
    J Cancer. 2021;12:111-123.
    PubMed    
    Abstract available

  101. YANG SL, Tan HX, Niu TT, Liu YK, et al
    The IFN-gamma-IDO1-kynureine pathway-induced autophagy in cervical cancer cell promotes phagocytosis of macrophage.
    Int J Biol Sci. 2021;17:339-352.
    PubMed    
    Abstract available

  102. AHMAD A, Ansari IA
    Carvacrol Exhibits Chemopreventive Potential against Cervical Cancer Cells via Caspase-Dependent Apoptosis and Abrogation of Cell Cycle Progression.
    Anticancer Agents Med Chem. 2020 Dec 30. pii: ACAMC-EPUB-112850.
    PubMed    
    Abstract available

  103. WANG J, Yang Z, Li W
    Deciphering the Role of Human Gastrointestinal Microbiota in the Pathogenesis of Vaginal Infection and Cervical Cancer.
    J Environ Pathol Toxicol Oncol. 2020;39:365-373.
    PubMed    
    Abstract available

  104. LIAO WH, Song XQ, Kong YJ, Bao RD, et al
    A novel Schiff base cobalt(III) complex induces a synergistic effect on cervical cancer cells by arresting early apoptosis stage.
    Biometals. 2021 Jan 3. pii: 10.1007/s10534-020-00278.
    PubMed    
    Abstract available

  105. WANG B, Tan Y, Yang X, Man X, et al
    Survival outcomes of neoadjuvant chemotherapy-related strategies compared with concurrent chemoradiotherapy for locally advanced cervical cancer: a meta-analysis of randomized controlled trials.
    Arch Gynecol Obstet. 2021 Jan 2. pii: 10.1007/s00404-020-05916.
    PubMed    
    Abstract available

  106. FUZZELL LN, Perkins R, Christy S, Lake PW, et al
    Hard to reach populations in cervical cancer screening in high income countries.
    Prev Med. 2020 Dec 31:106400. doi: 10.1016/j.ypmed.2020.106400.
    PubMed    
    Abstract available

  107. MALONE C, Buist DSM, Tiro J, Barlow W, et al
    Out of reach? Correlates of cervical cancer underscreening in women with varying levels of healthcare interactions in a United States integrated delivery system.
    Prev Med. 2020 Dec 31:106410. doi: 10.1016/j.ypmed.2020.106410.
    PubMed    
    Abstract available

  108. GATES A, Pillay J, Reynolds D, Stirling R, et al
    Screening for the prevention and early detection of cervical cancer: protocol for systematic reviews to inform Canadian recommendations.
    Syst Rev. 2021;10:2.
    PubMed    
    Abstract available

  109. PORRAS C, Tsang SH, Herrero R, Guillen D, et al
    Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial.
    Lancet Oncol. 2020;21:1643-1652.
    PubMed    
    Abstract available

  110. ADEBAMOWO SN, Adeyemo AA, Rotimi CN, Olaniyan O, et al
    Genome-wide association study of prevalent and persistent cervical high-risk human papillomavirus (HPV) infection.
    BMC Med Genet. 2020;21:231.
    PubMed    
    Abstract available

  111. HATCH B, Hoopes M, Darney BG, Marino M, et al
    Impacts of the Affordable Care Act on Receipt of Women's Preventive Services in Community Health Centers in Medicaid Expansion and Nonexpansion States.
    Womens Health Issues. 2021;31:9-16.
    PubMed    
    Abstract available

  112. HU X, Jing M, Zhang M, Yang P, et al
    Responsiveness and minimal clinically important difference of the EQ-5D-5L in cervical intraepithelial neoplasia: a longitudinal study.
    Health Qual Life Outcomes. 2020;18:324.
    PubMed    
    Abstract available

  113. UEDA Y, Yagi A, Abe H, Nakagawa S, et al
    The last strategy for re-dissemination of HPV vaccination in Japan while still under the suspension of the governmental recommendation.
    Sci Rep. 2020;10:16091.
    PubMed    
    Abstract available

  114. LEE CY, Chen YL, Chiang YC, Cheng CY, et al
    Outcome and Subsequent Pregnancy after Fertility-Sparing Surgery of Early-Stage Cervical Cancers.
    Int J Environ Res Public Health. 2020;17.
    PubMed    
    Abstract available

  115. MENSAH K, Assoumou N, Duchesne V, Pourette D, et al
    Acceptability of HPV screening among HIV-infected women attending an HIV-dedicated clinic in Abidjan, Cote d'Ivoire.
    BMC Womens Health. 2020;20:155.
    PubMed    
    Abstract available

  116. ISABIRYE A, Mbonye M, Asiimwe JB, Kwagala B, et al
    Factors associated with HPV vaccination uptake in Uganda: a multi-level analysis.
    BMC Womens Health. 2020;20:145.
    PubMed    
    Abstract available

  117. BARWAL TS, Sharma U, Vasquez KM, Prakash H, et al
    A panel of circulating long non-coding RNAs as liquid biopsy biomarkers for breast and cervical cancers.
    Biochimie. 2020;176:62-70.
    PubMed    
    Abstract available

  118. REZNICZEK GA, Hecken JM, Rehman S, Dogan A, et al
    Syringe or mask? Loop electrosurgical excision procedure under local or general anesthesia: a randomized trial.
    Am J Obstet Gynecol. 2020;223:888.
    PubMed    
    Abstract available

  119. ZHOU Q, Yao X, Wu C, Chen S, et al
    Knockdown of Ubiquitin-Specific Protease 53 Enhances the Radiosensitivity of Human Cervical Squamous Cell Carcinoma by Regulating DNA Damage-Binding Protein 2.
    Technol Cancer Res Treat. 2020;19:1533033820929792.
    PubMed    
    Abstract available

  120. LEE S, Hitt WC
    Clinical Applications of Telemedicine in Gynecology and Women's Health.
    Obstet Gynecol Clin North Am. 2020;47:259-270.
    PubMed    
    Abstract available

  121. ZHAO Z, Ji M, Wang Q, He N, et al
    Ca(2+) signaling modulation using cancer cell membrane coated chitosan nanoparticles to combat multidrug resistance of cancer.
    Carbohydr Polym. 2020;238:116073.
    PubMed    
    Abstract available

  122. SITARZ K, Czamara K, Bialecka J, Klimek M, et al
    HPV Infection Significantly Accelerates Glycogen Metabolism in Cervical Cells with Large Nuclei: Raman Microscopic Study with Subcellular Resolution.
    Int J Mol Sci. 2020;21.
    PubMed    
    Abstract available

  123. WANG S, He X, Meng F, Pan Q, et al
    Application of the Cobas 4800 System for the Detection of High-Risk Human Papillomavirus in 5650 Asymptomatic Women.
    Biomed Res Int. 2020;2020:1635324.
    PubMed    
    Abstract available

  124. YAGO-IBANEZ J, Garcia-Pastor C, Lucio-Cazana FJ, Fernandez-Martinez AB, et al
    Retinoic acid receptor-beta prevents cisplatin-induced proximal tubular cell death.
    Biochim Biophys Acta Mol Basis Dis. 2020;1866:165795.
    PubMed    
    Abstract available

  125. ZAFFAR M, Pradhan A
    Assessment of anisotropy of collagen structures through spatial frequencies of Mueller matrix images for cervical pre-cancer detection.
    Appl Opt. 2020;59:1237-1248.
    PubMed    
    Abstract available

  126. MORCOS M, Enger SA
    Monte Carlo dosimetry study of novel rotating MRI-compatible shielded tandems for intensity modulated cervix brachytherapy.
    Phys Med. 2020;71:178-184.
    PubMed    
    Abstract available

  127. XIA C, He Z, Cai Y, Liang S, et al
    Vorinostat upregulates MICA via the PI3K/Akt pathway to enhance the ability of natural killer cells to kill tumor cells.
    Eur J Pharmacol. 2020;875:173057.
    PubMed    
    Abstract available

  128. ALHAMLAN FS, Khayat HH, Obeid DA, Tulba AM, et al
    Clinical comparison of two human papillomavirus detection assays: GenoFlow and reverse line blot.
    J Infect Dev Ctries. 2020;14:97-103.
    PubMed    
    Abstract available

  129. VARSHNEY S, Maheshwari V, Aijaz M, Alam K, et al
    Role and significance of HER-2/neu as a biomarker in the premalignant and malignant lesions of uterine cervix.
    Ann Diagn Pathol. 2020;45:151443.
    PubMed    
    Abstract available

  130. CABRAL-ROMERO C, Solis-Soto JM, Sanchez-Perez Y, Pineda-Aguilar N, et al
    Antitumor activity of a hydrogel loaded with lipophilic bismuth nanoparticles on cervical, prostate, and colon human cancer cells.
    Anticancer Drugs. 2020;31:251-259.
    PubMed    
    Abstract available

  131. SANABRIA D, Rodriguez J, Pecci P, Ardila E, et al
    Same-Day Discharge in Minimally Invasive Surgery Performed by Gynecologic Oncologists: A Review of Patient Selection.
    J Minim Invasive Gynecol. 2020;27:816-825.
    PubMed    
    Abstract available

  132. MEDINA RANGEL PX, Moroni E, Merlier F, Gheber LA, et al
    Chemical Antibody Mimics Inhibit Cadherin-Mediated Cell-Cell Adhesion: A Promising Strategy for Cancer Therapy.
    Angew Chem Int Ed Engl. 2020;59:2816-2822.
    PubMed    
    Abstract available

  133. ZHOU Y, Liu H, Wang J, Wang X, et al
    DeltaNp63alpha exerts antitumor functions in cervical squamous cell carcinoma.
    Oncogene. 2020;39:905-921.
    PubMed    
    Abstract available

  134. CHEN S, Qi X, Chen L, Li F, et al
    Laparoendoscopic Single-site Radical Hysterectomy: Sufficient Exposure via Effective Suspension.
    J Minim Invasive Gynecol. 2020;27:809-810.
    PubMed    
    Abstract available

  135. TOPDAGI YILMAZ EP, Cimilli Senocak GN, Topdagi YE, Aynaoglu Yildiz G, et al
    Incidence of occult malignancies identified during hysterectomies performed for benign indications.
    J Gynecol Obstet Hum Reprod. 2020;49:101620.
    PubMed    
    Abstract available

  136. LOUVANTO K, Aro K, Nedjai B, Butzow R, et al
    Methylation in Predicting Progression of Untreated High-grade Cervical Intraepithelial Neoplasia.
    Clin Infect Dis. 2020;70:2582-2590.
    PubMed    
    Abstract available

  137. DEL MISTRO A
    Avoiding Unnecessary Treatment of Cervical Intraepithelial Neoplasia Grade 2.
    Clin Infect Dis. 2020;70:2591-2592.
    PubMed    


  138. DOULIGERIS A, Prodromidou A, Psomiadou V, Iavazzo C, et al
    Abdominal radical trachelectomy during pregnancy: A systematic review of the literature.
    J Gynecol Obstet Hum Reprod. 2020;49:101607.
    PubMed    
    Abstract available

  139. ABOZINA A, Singh N, Blake C
    Transtubal Spread of a Superficially Invasive Cervical Adenocarcinoma to the Ovaries After 11 Years.
    Int J Gynecol Pathol. 2020;39:296-300.
    PubMed    
    Abstract available

  140. AKAR S, Harmankaya I, Ugras S, Celik C, et al
    Expression and Clinical Significance of Nicotinamide N-Methyltransferase in Cervical Squamous Cell Carcinoma.
    Int J Gynecol Pathol. 2020;39:289-295.
    PubMed    
    Abstract available

  141. VERDOODT F, Dehlendorff C, Kjaer SK
    Dose-related effectiveness of quadrivalent human papillomavirus vaccine against cervical intraepithelial neoplasia: A Danish nationwide cohort study.
    Clin Infect Dis. 2019 Mar 20. pii: 5403490. doi: 10.1093.
    PubMed    
    Abstract available

  142. KAZMIERCZAK K, Nowakowski B
    Radical hysterectomy and its importance in the concept of cervical cancer treatment.
    Ginekol Pol. 2021 Jan 15. pii: VM/OJS/J/69806. doi: 10.5603/GP.a2020.0148.
    PubMed    
    Abstract available

  143. TSEGAY A, Araya T, Amare K, G/Tsadik F, et al
    Knowledge, Attitude, and Practice on Cervical Cancer Screening and Associated Factors Among Women Aged 15-49 Years in Adigrat Town, Northern Ethiopia, 2019: A Community-Based Cross-Sectional Study.
    Int J Womens Health. 2021;12:1283-1298.
    PubMed    
    Abstract available

  144. XUE H, Sun Z, Wu W, Du D, et al
    Identification of Hub Genes as Potential Prognostic Biomarkers in Cervical Cancer Using Comprehensive Bioinformatics Analysis and Validation Studies.
    Cancer Manag Res. 2021;13:117-131.
    PubMed    
    Abstract available

  145. ZHAO D, Li B, Zheng S, Ou Z, et al
    Separate lateral parametrial lymph node dissection improves detection rate of parametrial lymph node metastasis in early-stage cervical cancer: 10-year clinical evaluation in a single center in China.
    Chin J Cancer Res. 2020;32:804-814.
    PubMed    
    Abstract available

  146. ZHANG S, Xu H, Zhang L, Qiao Y, et al
    Cervical cancer: Epidemiology, risk factors and screening.
    Chin J Cancer Res. 2020;32:720-728.
    PubMed    
    Abstract available

  147. SUN Q, Qi X, Zhang W, Li X, et al
    Knockdown of circRNA_0007534 suppresses the tumorigenesis of cervical cancer via miR-206/GREM1 axis.
    Cancer Cell Int. 2021;21:54.
    PubMed    
    Abstract available

  148. PAN L, Xu C, Mei J, Chen Y, et al
    Argonaute 3 (AGO3) promotes malignancy potential of cervical cancer via regulation of Wnt/beta-catenin signaling pathway.
    Reprod Biol. 2021;21:100479.
    PubMed    
    Abstract available

  149. SABATINO SA, Thompson TD, White MC, Shapiro JA, et al
    Cancer Screening Test Receipt - United States, 2018.
    MMWR Morb Mortal Wkly Rep. 2021;70:29-35.
    PubMed    
    Abstract available

  150. RANDALL LM, Mayadev J, Monk BJ
    Sequential Chemotherapy for Early-Stage, Post-Radical Hysterectomy Cervical Cancer: Are the STARS Aligned?
    JAMA Oncol. 2021 Jan 14. pii: 2774865. doi: 10.1001/jamaoncol.2020.7184.
    PubMed    


  151. ORTIZ AP, Ortiz-Ortiz KJ, Colon-Lopez V, Tortolero-Luna G, et al
    Incidence of Cervical Cancer in Puerto Rico, 2001-2017.
    JAMA Oncol. 2021 Jan 14. pii: 2774866. doi: 10.1001/jamaoncol.2020.7488.
    PubMed    


  152. HUANG H, Feng YL, Wan T, Zhang YN, et al
    Effectiveness of Sequential Chemoradiation vs Concurrent Chemoradiation or Radiation Alone in Adjuvant Treatment After Hysterectomy for Cervical Cancer: The STARS Phase 3 Randomized Clinical Trial.
    JAMA Oncol. 2021 Jan 14. pii: 2774871. doi: 10.1001/jamaoncol.2020.7168.
    PubMed    
    Abstract available

  153. LEE H, Oh C, Kim S, Dey DK, et al
    Metasequoia glyptostroboides potentiates anticancer effect against cervical cancer via intrinsic apoptosis pathway.
    Sci Rep. 2021;11:894.
    PubMed    
    Abstract available

  154. EL ALIANI A, El Abid H, El Mallali Y, Attaleb M, et al
    Association between gene promoter methylation and cervical cancer development: global distribution and a meta-analysis.
    Cancer Epidemiol Biomarkers Prev. 2021 Jan 13. pii: 1055-9965.EPI-20-0833.
    PubMed    
    Abstract available

  155. PERERA KCM, Mapitigama N, Abeysena H
    The feasibility of new HPV/DNA test as a primary cervical cancer screening method among 35- years- old ever-married women in Kalutara district; a cross-sectional study.
    BMC Public Health. 2021;21:131.
    PubMed    
    Abstract available

  156. HU J, Zhang Y, Tang N, Lu Y, et al
    Discovery of novel 1,3,5-triazine derivatives as potent inhibitor of cervical cancer via dual inhibition of PI3K/mTOR.
    Bioorg Med Chem. 2021;32:115997.
    PubMed    
    Abstract available

  157. ZAHRA K, Patel S, Dey T, Pandey U, et al
    A study of oxidative stress in cervical cancer- an institutional study.
    Biochem Biophys Rep. 2020;25:100881.
    PubMed    
    Abstract available

  158. BORCOMAN E, Le Tourneau C
    Keynote-158 study, FDA granted accelerated approval of pembrolizumab for the treatment of patients with advanced PD-L1-positive cervical cancer.
    Ann Transl Med. 2020;8:1611.
    PubMed    


  159. MA X, Li Y, Wen J, Zhao Y, et al
    m6A RNA methylation regulators contribute to malignant development and have a clinical prognostic effect on cervical cancer.
    Am J Transl Res. 2020;12:8137-8146.
    PubMed    
    Abstract available

  160. NAKATA M, Yoshida K, Shimbo T, Yoshikawa N, et al
    High-dose-rate interstitial brachytherapy with hypoxic radiosensitizer KORTUC II for unresectable pelvic sidewall recurrence of uterine cervical cancer: a case report.
    J Contemp Brachytherapy. 2020;12:606-611.
    PubMed    
    Abstract available

  161. CZAJKOWSKI P, Zwierzchowski G, Piotrowski T
    Accuracy of registrations between cone-beam computed tomography and conventional computed tomography images and dose mapping methods in RaySearch software for the bladder during brachytherapy of cervical cancer patients.
    J Contemp Brachytherapy. 2020;12:593-600.
    PubMed    
    Abstract available

  162. PASEK M, Suchocka L, Osuch-Pecak G, Muzykiewicz K, et al
    Longitudinal Health-Related Quality of Life Study among Cervical Cancer Patients Treated with Radiotherapy.
    J Clin Med. 2021;10.
    PubMed    
    Abstract available

  163. MOGA MA, Dima L, Balan A, Blidaru A, et al
    Are Bioactive Molecules from Seaweeds a Novel and Challenging Option for the Prevention of HPV Infection and Cervical Cancer Therapy?-A Review.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  164. MEZA-MENCHACA T, Poblete-Naredo I, Albores-Medina A, Pedraza-Chaverri J, et al
    Ergosterol Peroxide Isolated from Oyster Medicinal Mushroom, Pleurotus ostreatus (Agaricomycetes), Potentially Induces Radiosensitivity in Cervical Cancer.
    Int J Med Mushrooms. 2020;22:1109-1119.
    PubMed    
    Abstract available

  165. PU J, He M, Pu Y, Liu Z, et al
    Knowledge about Human Papillomavirus and Cervical Cancer Prevention among Intern Nurses.
    Asia Pac J Oncol Nurs. 2020;8:46-50.
    PubMed    
    Abstract available

  166. BAI L, Yao N, Qiao G, Wu L, et al
    CXCL5 contributes to the tumorigenicity of cervical cancer and is post-transcriptionally regulated by miR-577.
    Int J Clin Exp Pathol. 2020;13:2984-2993.
    PubMed    
    Abstract available

  167. ROTMAN J, den Otter LAS, Bleeker MCG, Samuels SS, et al
    PD-L1 and PD-L2 Expression in Cervical Cancer: Regulation and Biomarker Potential.
    Front Immunol. 2020;11:596825.
    PubMed    
    Abstract available

  168. SUBRAMANIAM Y, Subban K, Chelliah J
    A novel synergistic anticancer effect of fungal cholestanol glucoside and paclitaxel: Apoptosis induced by an intrinsic pathway through ROS generation in cervical cancer cell line (HeLa).
    Toxicol In Vitro. 2021;72:105079.
    PubMed    
    Abstract available

  169. ZUR R, Casson M, Bellaire J, Yudin M, et al
    Unintended Consequences: The Impact of Cervical Cancer Screening Guidelines on Rates of STI Screening in Primary Care.
    J Obstet Gynaecol Can. 2020 Nov 5. pii: S1701-2163(20)30879.
    PubMed    
    Abstract available

  170. LIU XY, Kong FZ, Du JJ, Chen DB, et al
    [Metastatic infiltrating lobular carcinoma of breast with cervical tumor as the first manifestation: a case report].
    Zhonghua Zhong Liu Za Zhi. 2020;42:981-982.
    PubMed    


  171. NAGAMMA T, Ashok L, Konuri A, Chandrasekaran V, et al
    Effectiveness of audio-visual and print media intervention on knowledge of cervical health among rural women in Southern India.
    Niger Postgrad Med J. 2020;27:343-347.
    PubMed    
    Abstract available

  172. IDEHEN EE, Pietila AM, Kangasniemi M
    Barriers and Facilitators to Cervical Screening among Migrant Women of African Origin: A Qualitative Study in Finland.
    Int J Environ Res Public Health. 2020;17.
    PubMed    
    Abstract available

  173. ZHANG J, Cheng K, Wang Z
    Prevalence and distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia in China: a meta-analysis.
    Arch Gynecol Obstet. 2020;302:1329-1337.
    PubMed    
    Abstract available

  174. CHO BJ, Choi YJ, Lee MJ, Kim JH, et al
    Classification of cervical neoplasms on colposcopic photography using deep learning.
    Sci Rep. 2020;10:13652.
    PubMed    
    Abstract available

  175. BOWDEN SJ, Lathouras K, Kyrgiou M
    Can DNA methylation tests improve the accuracy of cervical screening?
    BJOG. 2021;128:515.
    PubMed    


  176. PALMER TJ
    Cervical screening with human papillomavirus primary testing: the way forward.
    BJOG. 2021;128:583.
    PubMed    


  177. JEPPSON PC
    A systematic review on the use of misoprostol at the time of open myomectomy.
    BJOG. 2021;128:484.
    PubMed    


  178. ALBERTSDOTTIR E, Juel J
    Quadruple synchronous primary cancers in a single patient.
    BMJ Case Rep. 2020;13.
    PubMed    
    Abstract available

  179. OGAWA C, Nakamura K, Matsuoka H, Matsubara Y, et al
    Risk of Gynecologic Cancer as Second versus First Primary Cancer in Japan.
    Acta Med Okayama. 2020;74:109-114.
    PubMed    
    Abstract available

  180. AGHAMIRI S, Talaei S, Roshanzamiri S, Zandsalimi F, et al
    Delivery of genome editing tools: A promising strategy for HPV-related cervical malignancy therapy.
    Expert Opin Drug Deliv. 2020;17:753-766.
    PubMed    
    Abstract available

  181. JIANG Y, Hu Z, Zuo Z, Li Y, et al
    Identification of Circulating MicroRNAs as a Promising Diagnostic Biomarker for Cervical Intraepithelial Neoplasia and Early Cancer: A Meta-Analysis.
    Biomed Res Int. 2020;2020:4947381.
    PubMed    
    Abstract available

  182. GERNIER F, Joly F, Klein D, Mercier M, et al
    Cancer-related fatigue among long-term survivors of breast, cervical, and colorectal cancer: a French registry-based controlled study.
    Support Care Cancer. 2020;28:5839-5849.
    PubMed    
    Abstract available

  183. ALHAKAMY NA, Alaofi AL, Ahmed OAA, Fahmy UA, et al
    Development of lipid membrane based assays to accurately predict the transfection efficiency of cell-penetrating peptide-based gene nanoparticles.
    Int J Pharm. 2020;580:119221.
    PubMed    
    Abstract available

  184. VORMITTAG-NOCITO E, Groth JV, Mohapatra G
    Next generation sequencing of cervical high grade dysplasia and invasive squamous cell carcinoma: A case study.
    Pathol Res Pract. 2020;216:152863.
    PubMed    
    Abstract available

  185. SUWANTHANANON C, Inthasorn P
    A comparison of the associations of Reid Colposcopic Index and Swede Score with cervical histology.
    J Obstet Gynaecol Res. 2020;46:618-624.
    PubMed    
    Abstract available

  186. BRACKNEY MM, Gargano JW, Hannagan SE, Meek J, et al
    Human Papillomavirus 16/18-Associated Cervical Lesions: Differences by Area-Based Measures of Race and Poverty.
    Am J Prev Med. 2020;58:e149-e157.
    PubMed    
    Abstract available

  187. PORTNOY A, Campos NG, Sy S, Burger EA, et al
    Impact and Cost-Effectiveness of Human Papillomavirus Vaccination Campaigns.
    Cancer Epidemiol Biomarkers Prev. 2020;29:22-30.
    PubMed    
    Abstract available

  188. ROBINSON S, Saleh J, Curry J, Mudaliar K, et al
    Pembrolizumab-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis in a Patient With Metastatic Cervical Squamous Cell Carcinoma: A Case Report.
    Am J Dermatopathol. 2019 Sep 17. doi: 10.1097/DAD.0000000000001527.
    PubMed    
    Abstract available

  189. REBOLJ M, Parmar D, Maroni R, Blyuss O, et al
    Concurrent participation in screening for cervical, breast, and bowel cancer in England.
    J Med Screen. 2020;27:9-17.
    PubMed    
    Abstract available

  190. KELLEN E, Nuyens C, Molleman C, Hoeck S, et al
    Uptake of cancer screening among adults with disabilities in Flanders (Belgium).
    J Med Screen. 2020;27:48-51.
    PubMed    
    Abstract available

  191. HEARLD KR, Budhwani H
    Human papillomavirus (HPV) and influenza vaccine behavior among Muslim women in the United States.
    Health Care Women Int. 2020;41:532-542.
    PubMed    
    Abstract available

  192. CHEN XJ, Wei WF, Wang ZC, Wang N, et al
    A novel lymphatic pattern promotes metastasis of cervical cancer in a hypoxic tumour-associated macrophage-dependent manner.
    Angiogenesis. 2021 Jan 23. pii: 10.1007/s10456-020-09766.
    PubMed    
    Abstract available

  193. GENNARI P, Gerken M, Meszaros J, Klinkhammer-Schalke M, et al
    Minimal-invasive or open approach for surgery of early cervical cancer: the treatment center matters.
    Arch Gynecol Obstet. 2021 Jan 22. pii: 10.1007/s00404-020-05947.
    PubMed    
    Abstract available

  194. STEINER A, Narva S, Rinta-Kiikka I, Hietanen S, et al
    Diagnostic efficiency of whole-body (18)F-FDG PET/MRI, MRI alone, and SUV and ADC values in staging of primary uterine cervical cancer.
    Cancer Imaging. 2021;21:16.
    PubMed    
    Abstract available

  195. ZHU J, Han S
    Histone deacetylase 10 exerts anti-tumor effects on cervical cancer via a novel microRNA-223/TXNIP/Wnt/beta-catenin pathway.
    IUBMB Life. 2021 Jan 22. doi: 10.1002/iub.2448.
    PubMed    
    Abstract available

  196. ZHU J, Han S
    Histone deacetylase 10 exerts anti-tumor effects on cervical cancer via a novel microRNA-223/TXNIP/Wnt/beta-catenin pathway.
    IUBMB Life. 2021 Jan 22. doi: 10.1002/iub.2450.
    PubMed    
    Abstract available

  197. SARKAR S, Tribedi P, Bhadra K
    Structure-activity insights of harmine targeting DNA, ROS inducing cytotoxicity with PARP mediated apoptosis against cervical cancer, anti-biofilm formation and in vivo therapeutic study.
    J Biomol Struct Dyn. 2021 Jan 22:1-23. doi: 10.1080/07391102.2021.1874533.
    PubMed    
    Abstract available

  198. KAWATA A, Taguchi A, Baba S, Miyamoto Y, et al
    A low preoperative albumin-to-globulin ratio is a negative prognostic factor in patients with surgically treated cervical cancer.
    Int J Clin Oncol. 2021 Jan 21. pii: 10.1007/s10147-021-01861.
    PubMed    
    Abstract available

  199. LEI D, Yang WT, Zheng PS
    HOXB4 inhibits the proliferation and tumorigenesis of cervical cancer cells by downregulating the activity of Wnt/beta-catenin signaling pathway.
    Cell Death Dis. 2021;12:105.
    PubMed    
    Abstract available

  200. DE LA CRUZ-CONCEPCION B, Espinoza-Rojo M, Alvarez-Fitz P, Illades-Aguiar B, et al
    Cytotoxicity of Ficus Crocata Extract on Cervical Cancer Cells and Protective Effect against Hydrogen Peroxide-Induced Oxidative Stress in HaCaT Non-Tumor Cells.
    Plants (Basel). 2021;10.
    PubMed    
    Abstract available

  201. SAUNDERS CL, Massou E, Waller J, Meads C, et al
    Cervical screening attendance and cervical cancer risk among women who have sex with women.
    J Med Screen. 2021 Jan 21:969141320987271. doi: 10.1177/0969141320987271.
    PubMed    
    Abstract available

  202. E AJYP, R S, K L, S A, et al
    Structural, vibrational, quantum chemical and thermal investigation of a nutraceutical drug in new zwitterionic cocrystal form (nicotinic acid: catechol) with enhanced cytotoxic activity in cervical cancer HeLa cell line.
    J Biomol Struct Dyn. 2021 Jan 21:1-14. doi: 10.1080/07391102.2021.1874534.
    PubMed    
    Abstract available

  203. GOKALP F
    The effective natural compounds for inhibiting Cervical cancer.
    Med Oncol. 2021;38:12.
    PubMed    
    Abstract available

  204. GUO F, Chen C, Liang Y, Ma S, et al
    Efficacy of the combination of endostar with chemotherapy on stage IVb and recurrent metastatic cervical cancer.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020;45:1412-1418.
    PubMed    
    Abstract available

  205. GENNIGENS C, De Cuypere M, Hermesse J, Kridelka F, et al
    Optimal treatment in locally advanced cervical cancer.
    Expert Rev Anticancer Ther. 2021 Jan 20. doi: 10.1080/14737140.2021.1879646.
    PubMed    
    Abstract available

  206. LI P, Chen L, Ni Y, Liu J, et al
    Comparison between laparoscopic and abdominal radical hysterectomy for stage IB1 and tumor size <2 cm cervical cancer with visible or invisible tumors: a multicentre retrospective study.
    J Gynecol Oncol. 2020 Dec 14. pii: 32.e17. doi: 10.3802/jgo.2021.
    PubMed    
    Abstract available

  207. WANG W, Li X, Xu Y, Guo W, et al
    Acetylation-stabilized chloride intracellular channel 1 exerts a tumor-promoting effect on cervical cancer cells by activating NF-kappaB.
    Cell Oncol (Dordr). 2021 Jan 19. pii: 10.1007/s13402-020-00582.
    PubMed    
    Abstract available

  208. YUAN Z, Cao D, Zhang Y, Shen K, et al
    Could Adjuvant Chemotherapy Improve Prognosis for Cervical Cancer Patients with Elevated Pretreatment Serum Squamous-Cell Carcinoma Antigen?
    Risk Manag Healthc Policy. 2021;14:109-116.
    PubMed    
    Abstract available

  209. BAI L, Sun W, Han Z, Tang H, et al
    CircSND1 Regulated by TNF-alpha Promotes the Migration and Invasion of Cervical Cancer Cells.
    Cancer Manag Res. 2021;13:259-275.
    PubMed    
    Abstract available

  210. REN L, Yang S, Cao Q, Tian J, et al
    CRNDE Contributes Cervical Cancer Progression by Regulating miR-4262/ZEB1 Axis.
    Onco Targets Ther. 2021;14:355-366.
    PubMed    
    Abstract available

  211. CHEN X, Zhou M, Fan W, Yang M, et al
    Combination of Sodium Cantharidinate with Cisplatin Synergistically Hampers Growth of Cervical Cancer.
    Drug Des Devel Ther. 2021;15:171-183.
    PubMed    
    Abstract available

  212. PARK SH, Kim M, Lee S, Jung W, et al
    Therapeutic Potential of Natural Products in Treatment of Cervical Cancer: A Review.
    Nutrients. 2021;13.
    PubMed    
    Abstract available

  213. STANCA M, Ciobanu V, Gheorghe M, Kiss SL, et al
    The Double Life-Saving Approach of Abdominal Radical Trachelectomy during Pregnancy for Early-Stage Cervical Cancer-An Overview of the Literature and Our Institutional Experience.
    J Pers Med. 2021;11.
    PubMed    
    Abstract available

  214. PERKINS RB, Guido RL, Saraiya M, Sawaya GF, et al
    Summary of Current Guidelines for Cervical Cancer Screening and Management of Abnormal Test Results: 2016-2020.
    J Womens Health (Larchmt). 2021;30:5-13.
    PubMed    
    Abstract available

  215. ZHANG Q, Yu X, Ouyang H, Zhang J, et al
    Whole-tumor texture model based on diffusion kurtosis imaging for assessing cervical cancer: a preliminary study.
    Eur Radiol. 2021 Jan 19. pii: 10.1007/s00330-020-07612.
    PubMed    
    Abstract available

  216. KUEHN BM
    WHO Launches Global Push to Eliminate Cervical Cancer.
    JAMA. 2021;325:213.
    PubMed    


  217. SUN L, Fan X, Shen C, Mu Z, et al
    Effect of psychological intervention combined with family model on postoperative rehabilitation in patients with cervical cancer.
    Minerva Med. 2021 Jan 19. pii: S0026-4806.20.07176.
    PubMed    


  218. ESTEVINHO C, Portela Carvalho A, Pinto AR, Costa F, et al
    Complete pelvic organ prolapse associated with cervical cancer.
    BMJ Case Rep. 2021;14.
    PubMed    


  219. SHAO LY, Wang RR, Sun YS, Yue Z, et al
    Delivery of MicroRNA-let-7c-5p by Biodegradable Silica Nanoparticles Suppresses Human Cervical Carcinoma Cell Proliferation and Migration.
    J Biomed Nanotechnol. 2020;16:1600-1611.
    PubMed    
    Abstract available

  220. JIA Z, Jiang L, Wang H, Gao W, et al
    MiR-218 restrains proliferation of cervical cancer cells via targeted regulation of HMGB1/RAGE pathway.
    J BUON. 2020;25:2683-2689.
    PubMed    
    Abstract available

  221. VEENA MS, Raychaudhuri S, Basak SK, Venkatesan N, et al
    Dysregulation of hsa-miR-34a and hsa-miR-449a leads to overexpression of PACS-1 and loss of DNA damage response (DDR) in cervical cancer.
    J Biol Chem. 2020;295:17169-17186.
    PubMed    
    Abstract available

  222. WANG Y, Zhang T, Peng S, Zhou R, et al
    Patterns of Treatment Failure after Concurrent Chemoradiotherapy or Adjuvant Radiotherapy in Patients with Locally Advanced Cervical Cancer.
    Oncol Res Treat. 2021 Jan 18:1-8. doi: 10.1159/000513170.
    PubMed    
    Abstract available


  223. Screening for cervical cancer.
    CA Cancer J Clin. 2020;70:347-348.
    PubMed    


  224. WOLDU BF, Lemu LG, Mandaro DE
    Comprehensive Knowledge towards Cervical Cancer and Associated Factors among Women in Durame Town, Southern Ethiopia.
    J Cancer Epidemiol. 2020;2020:4263439.
    PubMed    
    Abstract available

  225. JIANG X, Yuan J, Dou Y, Zeng D, et al
    Lipopolysaccharide Affects the Proliferation and Glucose Metabolism of Cervical Cancer Cells Through the FRA1/MDM2/p53 Pathway.
    Int J Med Sci. 2021;18:1030-1038.
    PubMed    
    Abstract available

  226. LUKAC A, Sulovic N, Smiljic S, Ilic AN, et al
    HPV TYPING AS A SCREENING PROGRAM FOR PREVENTION AND EARLY DETECTION OF CERVICAL CANCER IN DIFFERENT MONTENEGRO REGIONS.
    Acta Clin Croat. 2020;59:294-302.
    PubMed    
    Abstract available

  227. TUNCER HA, Tuncer SF
    The effect of age On cervical cancer screening in women aged 20-29.
    Acta Clin Croat. 2020;59:277-284.
    PubMed    
    Abstract available

  228. WANG MC, McCown PJ, Schiefelbein GE, Brown JA, et al
    Secondary Structural Model of MALAT1 Becomes Unstructured in Chronic Myeloid Leukemia and Undergoes Structural Rearrangement in Cervical Cancer.
    Noncoding RNA. 2021;7.
    PubMed    
    Abstract available

  229. LAURIA L, Lega I, Pizzi E, Donati S, et al
    [Family Care Centres for health protection and promotion of individuals and communities: a reflection at the time of the Coronavirus].
    Epidemiol Prev. 2020;44.
    PubMed    
    Abstract available

  230. MANTELLINI P, Battisti F, Armaroli P, Giubilato P, et al
    [Oncological organized screening programmes in the COVID-19 era: an Italian survey on accrued delays, reboot velocity, and diagnostic delay estimates].
    Epidemiol Prev. 2020;44.
    PubMed    
    Abstract available

  231. BUSSANI C, Malentacchi F, Andersson KL, Fambrini M, et al
    High grade cervical intraepithelial neoplasia positive biopsy: the importance of accurate pre-operative workup.
    Minerva Ginecol. 2020;72:413-419.
    PubMed    
    Abstract available

  232. CODY P, Tobe K, Abe M, Elbasha EH, et al
    Public health impact and cost effectiveness of routine and catch-up vaccination of girls and women with a nine-valent HPV vaccine in Japan: a model-based study.
    BMC Infect Dis. 2021;21:11.
    PubMed    
    Abstract available

  233. EDATHARA PM, Chintalapally S, Makani VKK, Pant C, et al
    Inhibitory role of oleanolic acid and esculetin in HeLa cells involve multiple signaling pathways.
    Gene. 2021;771:145370.
    PubMed    
    Abstract available

  234. FARMER E, Cheng MA, Hung CF, Wu TC, et al
    Vaccination Strategies for the Control and Treatment of HPV Infection and HPV-Associated Cancer.
    Recent Results Cancer Res. 2021;217:157-195.
    PubMed    
    Abstract available

  235. ACAMPORA A, Grossi A, Barbara A, Colamesta V, et al
    Increasing HPV Vaccination Uptake among Adolescents: A Systematic Review.
    Int J Environ Res Public Health. 2020;17.
    PubMed    
    Abstract available

  236. NOGUCHI T, Zaitsu M, Oki I, Haruyama Y, et al
    Recent Increasing Incidence of Early-Stage Cervical Cancers of the Squamous Cell Carcinoma Subtype among Young Women.
    Int J Environ Res Public Health. 2020;17.
    PubMed    
    Abstract available

  237. KAYIKCIOGLU F, Kucukyildiz IA, Gunes M, Ozelci R, et al
    Relationship between contraceptive methods and human papillomavirus positivity.
    Arch Gynecol Obstet. 2020;302:1407-1412.
    PubMed    
    Abstract available

  238. MOUGIN C
    [Vaccination against papillomaviruses: 10 key messages].
    Rev Prat. 2020;70:111.
    PubMed    


  239. DIB F, Launay O
    [Human papillomavirus vaccination : pharmacovigilance data].
    Rev Prat. 2020;70:96-98.
    PubMed    


  240. JANSEN E, Naber SK, Aitken CA, de Koning HJ, et al
    Cost-effectiveness of HPV-based cervical screening based on first year results in the Netherlands: a modelling study.
    BJOG. 2021;128:573-582.
    PubMed    
    Abstract available

  241. KREMER WW, Steenbergen R, Heideman D, Kenter GG, et al
    The use of host cell DNA methylation analysis in the detection and management of women with advanced cervical intraepithelial neoplasia: a review.
    BJOG. 2021;128:504-514.
    PubMed    
    Abstract available

  242. KARAM A, Dorigo O
    Minimally Invasive Surgery for Gynecologic Cancers-A Cautionary Tale.
    JAMA Oncol. 2020;6:991-993.
    PubMed    


  243. HOU J, Kan C, Zhu Y, Zhang Y, et al
    Cinnamolide sesquiterpene lactone suppresses in vitro and in vivo cancer cell growth in cisplatin-resistant human cervical carcinoma cells by inducing mitochondrial mediated apoptosis, caspase activation, loss of MMP and targeting Akt/beta-Catenin sig
    J BUON. 2020;25:709-715.
    PubMed    
    Abstract available

  244. MEDHIN LB, Tekle LA, Achila OO, Said S, et al
    Incidence of Cervical, Ovarian and Uterine Cancer in Eritrea: Data from the National Health Laboratory, 2011-2017.
    Sci Rep. 2020;10:9099.
    PubMed    
    Abstract available

  245. CHALMERS I
    The "unfortunate experiment" that was not, and the indebtedness of women and children to Herbert ("Herb") Green (1916-2001).
    J Clin Epidemiol. 2020;122:A14-A20.
    PubMed    
    Abstract available

  246. JONES OS, Vassie C, Emanuel O, Lechner M, et al
    Targeting key groups using a low-cost strategy to increase HPV awareness and vaccine uptake.
    Vaccine. 2020;38:4059.
    PubMed    


  247. LUND KV, Simonsen TG, Kristensen GB, Rofstad EK, et al
    DCE-MRI of locally-advanced carcinoma of the uterine cervix: Tofts analysis versus non-model-based analyses.
    Radiat Oncol. 2020;15:79.
    PubMed    
    Abstract available

  248. BISELLI-MONTEIRO M, Ferracini AC, Sarian LO, Derchain SFM, et al
    Influence of Gender and Undergraduate Course on the Knowledge about HPV and HPV Vaccine, and Vaccination Rate among Students of a Public University.
    Rev Bras Ginecol Obstet. 2020;42:96-105.
    PubMed    
    Abstract available

  249. HACKING S, Chavarria H, Jin C, Perry A, et al
    Landscape of Immune Checkpoint Inhibition in Carcinosarcoma (MMMT): Analysis of IDO-1, PD-L1 and PD-1.
    Pathol Res Pract. 2020;216:152847.
    PubMed    
    Abstract available

  250. BURGOS-TERUEL A, Bernet L, Gil-Tomas JJ, Jover-Garcia J, et al
    Human Papillomavirus in the region of La Ribera-Valencia: Present and future.
    Rev Esp Quimioter. 2020;33:103-109.
    PubMed    
    Abstract available

  251. VAN KOL KG, Ebisch RM, Piek JM, Zusterzeel PL, et al
    Salvage surgery for patients with residual disease after chemoradiation therapy for locally advanced cervical cancer: a systematic review on indication, complications and survival.
    Acta Obstet Gynecol Scand. 2021 Jan 20. doi: 10.1111/aogs.14093.
    PubMed    
    Abstract available

  252. TURASHVILI G, Samore WR, Oliva E, Ioffe O, et al
    Secondary Involvement of the Uterine Cervix by Nongynecologic Neoplasms: A Detailed Clinicopathologic Analysis.
    Am J Surg Pathol. 2020 Sep 8. doi: 10.1097/PAS.0000000000001578.
    PubMed    
    Abstract available

  253. SALCEDO MP, Sood AK, Jhingran A, Eifel PJ, et al
    Pelvic fractures and changes in bone mineral density after radiotherapy for cervical, endometrial, and vaginal cancer: A prospective study of 239 women.
    Cancer. 2020 Mar 3. doi: 10.1002/cncr.32807.
    PubMed    
    Abstract available

  254. MATSUI T, Tamoto R, Iwasa A, Mimura M, et al
    Nonlinear optics with near-infrared excitation enable real-time quantitative diagnosis of human cervical cancers.
    Cancer Res. 2020 Jul 23. pii: 0008-5472.CAN-20-0348.
    PubMed    
    Abstract available

  255. LI F, Zhang Z, Cai J, Chen X, et al
    Primary preclinical and clinical Evaluation of 68Ga-DOTA-TMVP1 as a novel VEGFR-3 PET Imaging Radiotracer in Gynecological Cancer.
    Clin Cancer Res. 2019 Dec 16. pii: 1078-0432.CCR-19-1845.
    PubMed    
    Abstract available

  256. CHOI YJ, Hur SY, Kim TJ, Hong SR, et al
    A Phase II, Prospective, Randomized, Multicenter, Open-Label Study of GX-188E, an HPV DNA Vaccine, in Patients with Cervical Intraepithelial Neoplasia 3.
    Clin Cancer Res. 2020;26:1616-1623.
    PubMed    
    Abstract available

  257. ZAPARDIEL I, Kocian R, Kohler C, Klat J, et al
    Voiding recovery after radical parametrectomy in cervical cancer patients: An international prospective multicentre trial - SENTIX.
    Gynecol Oncol. 2021 Jan 5. pii: S0090-8258(20)34221.
    PubMed    
    Abstract available

  258. DAHLMAN D, Li X, Magnusson H, Sundquist J, et al
    Cervical cancer among Swedish women with drug use disorders: A nationwide epidemiological study.
    Gynecol Oncol. 2020 Dec 31. pii: S0090-8258(20)34214.
    PubMed    
    Abstract available

  259. VASSEUR D, Lopez J, Croce S, Tondeur G, et al
    Transcriptome profiling of gastric-type endocervical adenocarcinomas identifies key signaling pathways for tumor progression.
    Gynecol Oncol. 2020;157:775-782.
    PubMed    
    Abstract available

  260. KALJOUW S, Jansen EEL, Aitken CA, Harrijvan LM, et al
    Reducing unnecessary referrals for colposcopy in hrHPV-positive women within the Dutch cervical cancer screening programme: A modelling study.
    Gynecol Oncol. 2021 Jan 12. pii: S0090-8258(20)34253.
    PubMed    
    Abstract available

  261. PARRA SG, Lopez-Orellana LM, Molina Duque AR, Carns JL, et al
    Cervical cancer prevention in El Salvador: A prospective evaluation of screening and triage strategies incorporating high-resolution microendoscopy to detect cervical precancer.
    Int J Cancer. 2020 Dec 24. doi: 10.1002/ijc.33454.
    PubMed    
    Abstract available

  262. TRICKEY A, May MT, Gill MJ, Grabar S, et al
    Cause-specific mortality after diagnosis of cancer among HIV-positive patients: a collaborative analysis of cohort studies.
    Int J Cancer. 2020 Jan 31. doi: 10.1002/ijc.32895.
    PubMed    
    Abstract available

  263. ZORZI M, Del Mistro A, Giorgi Rossi P, Laurino L, et al
    Risk of CIN2 or more severe lesions after negative HPV-mRNA E6/E7 overexpression assay and after negative HPV-DNA test: concurrent cohorts with a 5-year follow up.
    Int J Cancer. 2019 Oct 3. doi: 10.1002/ijc.32695.
    PubMed    
    Abstract available

  264. ORANG'O EO, Emont JP, Ermel AC, Liu T, et al
    Detection of types of HPV among HIV-infected and HIV-uninfected Kenyan women undergoing cryotherapy or loop electrosurgical excision procedure.
    Int J Gynaecol Obstet. 2020 Jul 26. doi: 10.1002/ijgo.13330.
    PubMed    
    Abstract available

  265. DANIEL GO, Musa J, Akindigh TM, Shinku F, et al
    Prevalence and predictors of precancerous cervical lesions among HIV-positive women in Jos, north-central Nigeria.
    Int J Gynaecol Obstet. 2020;151:253-259.
    PubMed    
    Abstract available

  266. TAMAUCHI S, Kajiyama H, Osuka S, Moriyama Y, et al
    Reduced response to controlled ovarian stimulation after radical trachelectomy: A pitfall of fertility-sparing surgery for cervical cancer.
    Int J Gynaecol Obstet. 2021 Jan 13. doi: 10.1002/ijgo.13529.
    PubMed    
    Abstract available

  267. KRAMER J
    Eradicating cervical cancer: Lessons learned from Rwanda and Australia.
    Int J Gynaecol Obstet. 2021 Jan 17. doi: 10.1002/ijgo.13601.
    PubMed    
    Abstract available

  268. PAREJA R
    Safety of minimally invasive radical hysterectomy in cervical tumors <2 cm.
    Int J Gynecol Cancer. 2020;30:572-574.
    PubMed    


  269. LIU H, Li Y, Zhang J, Wu N, et al
    ErbB2 Receptor Tyrosine Kinase 2 is negatively regulated by the p53responsive microRNA31845p in cervical cancer cells.
    Oncol Rep. 2020 Nov 19. doi: 10.3892/or.2020.7862.
    PubMed    
    Abstract available

  270. PETRIC P, Lindegaard JC, Sturdza A, Fokdal L, et al
    Results of Image guided brachytherapy for stage IB cervical cancer in the RetroEMBRACE study.
    Radiother Oncol. 2021 Jan 18. pii: S0167-8140(21)00005.
    PubMed    
    Abstract available

  271. ITO M, Kodaira T, Koide Y, Okuda T, et al
    Role of high-dose salvage radiotherapy for oligometastases of the localised abdominal/pelvic lymph nodes: a retrospective study.
    BMC Cancer. 2020;20:540.
    PubMed    
    Abstract available

  272. VAN DE LAAR RLO, Hofhuis W, Duijnhoven RG, Polinder S, et al
    Adjuvant VACcination against HPV in surgical treatment of Cervical Intra-epithelial Neoplasia (VACCIN study) a study protocol for a randomised controlled trial.
    BMC Cancer. 2020;20:539.
    PubMed    
    Abstract available

  273. BRUNO MT, Scalia G, Cassaro N, Boemi S, et al
    Multiple HPV 16 infection with two strains: a possible marker of neoplastic progression.
    BMC Cancer. 2020;20:444.
    PubMed    
    Abstract available

  274. ZHANG J, Zhang D, Yang Z, Wang X, et al
    The role of human papillomavirus genotyping for detecting high-grade intraepithelial neoplasia or cancer in HPV-positive women with normal cytology: a study from a hospital in northeastern China.
    BMC Cancer. 2020;20:443.
    PubMed    
    Abstract available

  275. GUO HT, Bi XH, Lei T, Lv X, et al
    Preoperative SCC-Ag as a predictive marker for the use of adjuvant chemotherapy in cervical squamous cell carcinoma with intermediate-risk factors.
    BMC Cancer. 2020;20:441.
    PubMed    
    Abstract available

  276. KATO M, Onoyama I, Kawakami M, Yoshida S, et al
    Downregulation of 5-hydroxymethylcytosine is associated with the progression of cervical intraepithelial neoplasia.
    PLoS One. 2020;15:e0241482.
    PubMed    
    Abstract available

  277. TOUNKARA FK, Teguete I, Guedou FA, Goma-Matsetse E, et al
    Human papillomavirus genotype distribution and factors associated among female sex workers in West Africa.
    PLoS One. 2020;15:e0242711.
    PubMed    
    Abstract available

  278. TAKU O, Meiring TL, Gustavsson I, Phohlo K, et al
    Acceptability of self- collection for human papillomavirus detection in the Eastern Cape, South Africa.
    PLoS One. 2020;15:e0241781.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;